Beam Therapeutics (BEAM) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Beam Therapeutics (BEAM) Company Statistics | The Fly

Beam Therapeutics

· BEAM

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

2.533 B

-0.29%

General

Market Cap: $2.53B
Enterprise Value: $2.54B
Shares Outstanding: 102,880,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 18.93%
Operating Margin: -242.27%
Net Profit Margin: -54.75%
FCF Margin: -238.90%
ROA: -6.16%
ROE: -7.70%
ROIC: -28.62%
Current Ratio: 14.57
Debt-to-Equity: 0.23
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 16.12
P/FCF: —
P/B: 2.36
EV/EBITDA: -42.18

Growth

Rev 1Y: 120.01%
Rev 1Y Fwd Est: -63.34%
Rev 3Y (CAGR): 31.88%
Rev 5Y (CAGR): 466.27%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $156.04M
Gross Margin: 18.93%
Operating Expenses: $407.57M
Operating Income: -$378.02M
Net Profit: -$85.43M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $219.83M
Working Capital: $1.1B
Total Assets: $1.39B
Net Debt: $27.53M
Total Liabilities: $319.19M
Total Equity: $1.07B

Cash Flow Statement (TTM)

Cash Flow from Operations: -$359.38M
Cash Flow from Investing: $189.46M
Cash Flow from Financing: $107.69M
Free Cash Flow: -$372.77M
Capital Expenditures: $13.39M